Table 1.
Baseline | Intervention period | Post-intervention | Ref | |||
---|---|---|---|---|---|---|
2 mon of age | 4 mon of age | 6 mon of age | 12 mon of age | |||
Growth parameters and clinical assessment | Weight-for-age, length-for-age, head circumference -for-age, BMI-for-age (z-score) | NS | NS | NS | NS | 15 |
Growth velocity (weight and length) | (EF + SF) > BF | 15 | ||||
% body fat | NS | NS | 15 | |||
Blood pressure (systolic and diastolic) | NS | NS | NS | NS | 17 | |
Blood biochemical assessment | Plasma Insulin | (EF + SF) > BF | (EF + SF) > BF | (EF + SF) > BF | 15 | |
Blood urea nitrogen | (EF + SF) > BF | (EF + SF) > BF | (EF + SF) > BF | 15 | ||
Total serum cholesterol | BF > SF, BF > EF | BF > EF > SF | BF > SF, EF > SF | NS | 17 | |
Serum LDL: HDL | BF > SF, BF > EF | BF > SF, BF > EF | BF > SF, BF > EF | NS | 17 | |
Serum triglyceride | NS | BF > EF > SF | NS | NS | 17 | |
Serum Leptin | NS | 17 | ||||
Serum High-molecular-weight adiponectin | NS | 17 | ||||
Leptin: fat mass | BF > SF, BF > EF | 17 | ||||
Serum homocysteine | BF > EF, BF > SF | BF > EF | BF > EF, SF > EF | NS | 17 | |
Inflammatory markers and immune development | Serum C-reactive protein | BF > EF, SF > EF | NS | 17 | ||
Serum IgG against pneumococci (serotypes 1, 5 and 14) | SF > EF | 67 | ||||
Fecal calprotectin | BF > EF, BF > SF | BF > EF, BF > SF | NS | 17 | ||
Bayley Scale of Infant and Toddler Development | Cognitive score | EF > SF | 15 | |||
Motor score (fine motor) | BF > SF, BF > EF | |||||
Verbal score (receptive) | BF > SF, BF > EF |
Footnote: NS: not significant.